Back to welcome
Back to languageselection
ST:
astringent
No:200
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
toner
RF1: OT
YR1:
CO1:
LU:
ST:
asymptomatic
No:201
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
without symptoms
RF1: OT/E
YR1:
CO1:
LU:
ST:
asystole
No:202
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
heart attack
RF1: OT/C
YR1:
CO1:
LU:
ST:
ataxia
No:203
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
lack of coordination
RF1: OT/E
YR1:
CO1:
LU:
ST:
atheromatosis
No:204
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
thickening of the arteries
RF1: E
YR1: 1994
CO1:
LU:
ST:
athetosis
No:205
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
cerebral palsy
RF1: C
YR1: 1992
CO1:
LU:
ST:
atony
No:206
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
lack of muscle tone
RF1: C
YR1: 1992
CO1:
LU:
ST:
atopic
No:207
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
allergic reaction
RF1: H
YR1: 1988
CO1:
LU:
ST:
atoxic
No:208
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
non-poisonous
RF1: OT
YR1:
CO1:
LU:
ST:
atrial
No:209
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
heart-related
RF1: OT
YR1:
CO1:
LU:
ST:
atrioventricular
No:210
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
heart-related
RF1: OT
YR1:
CO1:
LU:
ST:
atrium
No:211
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
part of the heart
RF1: OT
YR1:
CO1:
LU:
ST:
atrophy
No:212
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
wasting
RF1: E
YR1: 1994
CO1:
LU:
ST:
atypical
No:213
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
unusual
RF1: OT
YR1:
CO1:
LU:
ST:
auditory
No:214
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
hearing-related
RF1: OT
YR1:
CO1:
LU:
ST:
aura
No:215
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
warning senstion
RF1: C
YR1: 1992
CO1:
LU:
ST:
aural
No:216
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
heard
RF1: OT
YR1:
CO1:
LU:
ST:
auricular
No:217
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
ear-related
RF1: OT
YR1:
CO1:
LU:
ST:
auscultation
No:218
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
listening with a stethoscope
RF1: OT/C
YR1:
CO1:
LU:
ST:
autoimmune
No:219
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
autoimmune
RF1: ID
YR1:
CO1:
LU:
ST:
automatism
No:220
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
repetitive movements
RF1: H
YR1: 1988
CO1:
LU:
ST:
autonomic
No:221
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
unconscious
RF1: H
YR1: 1988
CO1:
LU:
ST:
azoospermia
No:222
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
lack of sperm
RF1: OT/E
YR1:
CO1:
LU:
ST:
azotaemia
No:223
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
kidney failure
RF1: C
YR1: 1992
CO1:
LU:
ST:
bacillus
No:224
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bacteria
RF1: OT
YR1:
CO1:
LU:
ST:
bacteraemia
No:225
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bacteria in the blood
RF1: C
YR1: 1992
CO1:
LU:
ST:
bactericide
No:226
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
anti-bacteria drug
RF1:OT
YR1:
CO1:
LU:
ST:
bacteriological
No:227
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bacteria study-related
RF1: OT
YR1:
CO1:
LU:
ST:
bacteriostatic
No:228
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
antibiotic
RF1: OT
YR1:
CO1:
LU:
ST:
bacteroid
No:229
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bacteria-like
RF1: OT
YR1:
CO1:
LU:
ST:
balanitis
No:230
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
swollen penis
RF1: C
YR1: 1992
CO1:
LU:
ST:
barrier
No:231
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
barrier
RF1: ID
YR1:
CO1:
LU:
ST:
basal
No:232
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
base
RF1: E
YR1: 1994
CO1:
LU:
ST:
base
No:233
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
base
RF1: ID
YR1:
CO1:
LU:
ST:
benign
No:234
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
non-malignant
RF1: OT
YR1:
CO1:
LU:
ST:
betablocker
No:235
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
betablocker
RF1: ID
YR1:
CO1:
LU:
ST:
betamimetic
No:236
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
betamimetic
RF1: UT
YR1:
CO1:
LU:
ST:
bilateral
No:237
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
two-sided
RF1: OT
YR1:
CO1:
LU:
ST:
biliary
No:238
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bile-related
RF1: OT
YR1:
CO1:
LU:
ST:
bioavailability
No:239
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
effectiveness
RF1: OT
YR1:
CO1:
LU:
ST:
biochemical
No:240
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
biochemical
RF1: ID
YR1:
CO1:
LU:
ST:
biodegradation
No:241
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
bio-degrading
RF1: OT
YR1:
CO1:
LU:
ST:
bioequivalent
No:242
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
equivalent
RF1: OT
YR1:
CO1:
LU:
ST:
biological
No:243
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
biological
RF1: ID
YR1:
CO1:
LU:
ST:
biopsy
No:244
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
biopsy
RF1: ID
YR1:
CO1:
LU:
ST:
biosynthesis
No:245
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
formation
RF1: OT
YR1:
CO1:
LU:
ST:
biotransformation
No:246
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
chemical changes
RF1: E
YR1: 1994
CO1:
LU:
ST:
biphasic
No:247
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
two-phase
RF1: E
YR1: 1994
CO1:
LU:
ST:
blepharitis
No:248
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
eyelid inflammation
RF1: OT/E
YR1:
CO1:
LU:
ST:
blister
pack
No:249
PR:
RF :
YR:
CO:
______________________________________________________________
ENPT :
blister pack
RF1: ID
YR1:
CO1:
LU: